Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Robert M. Dean"'
Autor:
Hayley Dysert, Jason Valent, Nathaniel Rosko, Robert M. Dean, Lisa Rybicki, Christy J. Samaras, Beth Faiman, Rajshekhar Chakraborty, Megan O. Nakashima, Faiz Anwer
Publikováno v:
British Journal of Haematology. 189:1074-1082
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma (MM) is lacking in the current literature. We evaluated 258 patients with relapsed MM, diagnosed from 2008 to 2015, to investigate the prognostic impact of deep immu
Autor:
Ronald Sobecks, Rabi Hanna, Mohamed A. Kharfan-Dabaja, Brad Pohlman, Betty K. Hamilton, Lisa Rybicki, Deepa Jagadeesh, Brian T. Hill, Robert M. Dean, Matt Kalaycio, Navneet S. Majhail, Brian J. Bolwell, Jessica El-Asmar
Publikováno v:
Biol Blood Marrow Transplant
Autologous hematopoietic cell transplantation (AHCT) is standard therapy for patients with chemosensitive, relapsed, diffuse large B cell lymphoma (DLBCL). We performed a retrospective cohort study to delineate subsequent (conditional) and relative s
Autor:
Beth Faiman, Christy J. Samaras, Jason Valent, Matt Kalaycio, Hien D. Liu, Navneet S. Majhail, Rajshekhar Chakraborty, Robert M. Dean, Jack Khouri, Lisa Rybicki, Jacqulyn Tomer
Publikováno v:
American Journal of Hematology. 94:439-445
Response rate and survival in multiple myeloma (MM) has improved in the era of proteasome inhibitors and immunomodulatory drugs. However, most patients eventually relapse with biochemical progression (BP) alone or with clinical features of end-organ
Autor:
Patrick Elder, Matt Kalaycio, Sara Singer, Brian J. Bolwell, Donna Abounader, Steven M. Devine, Samantha Jaglowski, Yvonne A. Efebera, Ronald Sobecks, Navneet S. Majhail, Sam Penza, Deepa Jagadeesh, Don M. Benson, Nidhi Sharma, Craig C. Hofmeister, Ashley E. Rosko, Robert M. Dean, Brad Pohlman, Brian T. Hill, Basem M. William, Sumithira Vasu, Qiuhong Zhao, Leslie A. Andritsos
Publikováno v:
Bone Marrow Transplantation. 54:1553-1561
High-dose chemotherapy followed by autologous hematopoietic cell transplantation (AHCT) is an effective salvage therapy for patients with relapsed chemosensitive non-Hodgkin’s lymphoma (NHL). However, the optimal conditioning regimen is unclear. Di
Autor:
Tamila L. Kindwall-Keller, Uday R. Popat, Jaroslaw P. Maciejewski, Bronwen E. Shaw, Robert J. Hayashi, Remco J. Molenaar, Navneet S. Majhail, David I. Marks, Robert F. Cornell, Adriana K. Malone, Richard F. Olsson, Ruta Brazauskas, Jean-Yves Cahn, Basem M. William, Nandita Khera, Joseph W. Fay, Amer Beitinjaneh, Ibrahim Ahmed, Amir Steinberg, Heather Landau, Yoshihiro Inamoto, Peiman Hematti, Heather B. Allewelt, Anne B. Warwick, Kimberly A. Kasow, Mary E.D. Flowers, Harry C. Schouten, Anita D'Souza, Jennifer Holter Chakrabarty, Minoo Battiwalla, Tomas Radivoyevitch, Robert M. Dean, Baldeep Wirk, Gorgun Akpek, Siddhartha Ganguly, Shahrukh K. Hashmi, Sonata Jodele, J. Douglas Rizzo, Matt Kalaycio, Zachariah DeFilipp, Robert Peter Gale, William A. Wood, Hillard M. Lazarus, Andrew Daly, Kenneth R. Cooke, Anuj Mahindra, Muneer H. Abidi, Heather R. Tecca, Sachiko Seo, Ashish Bajel, Betty K. Hamilton, Mahmoud Aljurf, David Buchbinder, Rachel J. Cook, Mark R. Litzow, Jean A. Yared, Gregory A. Hale, Bipin N. Savani, Mikkael A. Sekeres, Mehdi Hamadani
Publikováno v:
Leukemia research, 74, 130-136. Elsevier Limited
Background Exposures to DNA-damaging drugs and ionizing radiations increase risks of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Methods 9028 recipients of hematopoietic cell autotransplants (1995–2010) for Hodgkin lymphoma (HL
Autor:
Matt Kalaycio, Ronald Sobecks, Donna Corrigan, Deepa Jagadeesh, Sagar S. Patel, Brad Pohlman, Aaron T. Gerds, Navneet S. Majhail, Brian T. Hill, Hien Liu, Betty K. Hamilton, Brian J. Bolwell, Lisa Rybicki, Rabi Hanna, Robert M. Dean
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1029-1034
Although day +100 survival among allogeneic hematopoietic cell transplantation (HCT) recipients has improved over time, longer-term survival remains a challenge. The aim of this study was to identify prognostic factors for survival among patients sur
Autor:
Betty K. Hamilton, Matt Kalaycio, Navneet S. Majhail, Steven Andresen, Yazeed Sawalha, Danyu Sun, Mitchell R. Smith, Deepa Jagadeesh, Lisa Rybicki, Hien Liu, Brian J. Bolwell, Brad Pohlman, Aaron T. Gerds, Brian T. Hill, Robert M. Dean, Ronald Sobecks
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e95-e102
Background Young fit patients with mantle cell lymphoma (MCL) are commonly treated with induction chemotherapy followed by high-dose chemotherapy and autologous hematopoietic cell transplantation (AHCT). Induction regimens with modifications of R-CHO
Autor:
Matt Kalaycio, Jack Khouri, Robert M. Dean, Donna Corrigan, Brad Pohlman, Aaron T. Gerds, Brian T. Hill, Betty K. Hamilton, Deepa Jagadeesh, Navneet S. Majhail, Brian J. Bolwell, Hien D. Liu, Ronald Sobecks, Frederic J. Reu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e374-e376
Autor:
Yazan F. Madanat, Brian T. Hill, Lisa Rybicki, Tomas Radivoyevitch, Mitchell R. Smith, Brad Pohlman, Robert M. Dean, Mikkael A. Sekeres, Deepa Jagadeesh, Matt Kalaycio
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:857-862
Hairy cell leukemia (HCL) is a rare hematologic malignancy with high response rates and long progression-free survival (PFS) after treatment with purine nucleoside analogs (PNAs; Pentostatin/Cladribine). However, treatment is not curative, and subseq
Autor:
John W. Sweetenham, Deepa Jagadeesh, Meredeth Shelley, Brian J. Bolwell, Brian T. Hill, Mitchell R. Smith, Brad Pohlman, Robert M. Dean, Stephen D. Smith
Publikováno v:
Leukemia & Lymphoma. 59:690-694
B-cell non-Hodgkin lymphomas (NHL) display dysregulation of pathways controlling cell proliferation and apoptosis. Combined proteasome and mTOR inhibition, demonstrated with bortezomib and everolimus in a preclinical model, thus warrants evaluation i